Abstract
Over two billion people worldwide are infected with the protozoan Toxoplasma gondii, which influences human behavior and cognition. Standard diagnosis methods involve costly medical tests, which prevents widespread testing and hinders the study of the infection’s effects. We propose and validate an inexpensive and easy-to-deploy diagnostic method for latent Toxoplasmosis infections using response times and finite-mixture models. A clinical study showed that the method is sensitive and accurate. A large, representative UK study showed that the infection’s consequences are relevant and pervasive, both economically (decrease in yearly income and employment) and behaviorally (increase in risky behaviors, stress, and depression).
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funded by the research budget of Carlos Alos-Ferrer while affiliated with the Center for Neuroeconomics at the University of Zurich (Switzerland)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Human Subjects Committee of the Faculty of Economics of the University of Zurich (OEC-IRB-2022-077) and the Ethics Committee in the Canton of Zurich (BASEC:2023-00366).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
* Funded by the research budget of Carlos Alós-Ferrer while affiliated with the Center for Neuroeconomics at the University of Zurich (Switzerland). No external funding was received. Preregistrations: ClinicalTrials.gov, NCT05860998, and AsPredicted.org, study number 108329. The authors thank Richard Thaler, James Heckman, and the attendees of the 7th Lindau Meeting on Economic Sciences.
Data Availability
Raw data files for each study and the code for the analyses are available on OSF.
https://osf.io/j2rku/?view_only=482ca01c948044a08f5a8244172d4090
